ID: ALA2409349

Max Phase: Preclinical

Molecular Formula: C19H15NO9

Molecular Weight: 401.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1cc(-c2ccc3c(c2)OCCO3)oc2cc(OCCO[N+](=O)[O-])cc(O)c12

Standard InChI:  InChI=1S/C19H15NO9/c21-13-8-12(25-5-6-28-20(23)24)9-18-19(13)14(22)10-16(29-18)11-1-2-15-17(7-11)27-4-3-26-15/h1-2,7-10,21H,3-6H2

Standard InChI Key:  BUNRKGHMULWETB-UHFFFAOYSA-N

Associated Targets(non-human)

Aldose reductase 1045 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 401.33Molecular Weight (Monoisotopic): 401.0747AlogP: 2.52#Rotatable Bonds: 6
Polar Surface Area: 130.50Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.36CX Basic pKa: CX LogP: 2.68CX LogD: 2.36
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.38Np Likeness Score: 0.25

References

1. Wang QQ, Cheng N, Zheng XW, Peng SM, Zou XQ..  (2013)  Synthesis of organic nitrates of luteolin as a novel class of potent aldose reductase inhibitors.,  21  (14): [PMID:23683835] [10.1016/j.bmc.2013.04.066]

Source